Literature DB >> 19626453

Protective antibody response following oral vaccination of feral pigeons (Columba livia) with Newcastle disease vaccine (strain I-2) coated on oiled rice.

P N Wambura1, C Wilson.   

Abstract

The novel vaccination technique for feral pigeons was developed in the present study. Multi-age feral pigeons were vaccinated orally with Newcastle disease (ND) strain I-2 vaccine coated on oiled rice. The results showed that 14 days after vaccination 40% of pigeons seroconverted with HI GMT of ≥3 log₂ whereas 28 days after vaccination the seroconversion rate of these birds reached 100%. Moreover, all vaccinated pigeons survived the challenge of virulent Newcastle disease virus (NDV). The findings from the present study indicated that the use of ND (strain I-2) vaccine in feral pigeons is feasible and resulted into the production of protective antibody response. Thus ND I-2 vaccine may prevent the spread of NDV to other birds particularly chickens. Furthermore the use of oral vaccine in feral multi-age pigeons overcomes the difficulty of catching these birds for individual vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626453     DOI: 10.1007/s11259-009-9309-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Susceptibility and protection of naive and vaccinated racing pigeons (Columbia livia) against exotic Newcastle disease virus from the California 2002-2003 outbreak.

Authors:  Darrell R Kapczynski; Mark G Wise; Daniel J King
Journal:  Avian Dis       Date:  2006-09       Impact factor: 1.577

2.  Efficacy of an inactivated aqueous-suspension Newcastle disease virus vaccine against paramyxovirus type 1 infection in young pigeons with varying amounts of maternal antibody.

Authors:  J P Duchatel; P H Flore; W Hermann; H Vindevogel
Journal:  Avian Pathol       Date:  1992       Impact factor: 3.378

3.  An outbreak of paramyxovirus encephalomyelitis in racing pigeons in India.

Authors:  A P Mangat; G Singh; B S Gill
Journal:  Vet Rec       Date:  1988-11-05       Impact factor: 2.695

4.  A standard haemagglutination inhibition test for Newcastle disease. (1). A comparison of macro and micro methods.

Authors:  W H Allan; R E Gough
Journal:  Vet Rec       Date:  1974-08-10       Impact factor: 2.695

5.  Antigenetically unusual Newcastle disease virus from racing pigeons in India.

Authors:  P Roy; A T Venugopalan; A Koteeswaran
Journal:  Trop Anim Health Prod       Date:  2000-06       Impact factor: 1.559

6.  Pigeon paramyxovirus: association with common avian pathogens in chickens and serologic survey in wild birds.

Authors:  H Toro; F J Hoerr; K Farmer; C C Dykstra; S R Roberts; M Perdue
Journal:  Avian Dis       Date:  2005-03       Impact factor: 1.577

7.  Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.

Authors:  Darrell R Kapczynski; Daniel J King
Journal:  Vaccine       Date:  2005-05-16       Impact factor: 3.641

Review 8.  The epidemiology and control of avian influenza and Newcastle disease.

Authors:  D J Alexander
Journal:  J Comp Pathol       Date:  1995-02       Impact factor: 1.311

9.  Oral vaccination of chickens with the V4 strain of Newcastle disease virus. Cooked and raw white rice as a vehicle.

Authors:  J L Samuel; Z Bensink; P B Spradbrow
Journal:  Trop Anim Health Prod       Date:  1993-02       Impact factor: 1.559

10.  An occurrence of Newcastle disease in pigeons: virological and serological studies on the isolates.

Authors:  F Biancifiori; A Fioroni
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1983       Impact factor: 2.268

View more
  1 in total

1.  Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.

Authors:  Jinliang Wang; Jie Yang; Jinying Ge; Ronghong Hua; Renqiang Liu; Xiaofeng Li; Xijun Wang; Yu Shao; Encheng Sun; Donglai Wu; Chengfeng Qin; Zhiyuan Wen; Zhigao Bu
Journal:  Virol J       Date:  2016-06-24       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.